Joseph McClellan
Vermögen: 568 400 $ am 30.06.2026
Vermögen: 568 400 $ am 30.06.2026
Joseph E.
McClellan is Chief Scientific Officer at Alvotech hf since 2019.
Dr. McClellan is Chief Operating Officer at Alvotech starting in 2025.
Formerly, Dr. McClellan was Global Head-Biosimilars Development & Medicine at Pfizer Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from the University of Florida, and an MBA from Northeastern University (China).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALVOTECH 0,05 % | 06.03.2026 | 154 038 ( 0,05 % ) | 568 400 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALVOTECH | Geschäftsführer | 12.11.2025 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University (China)
Northeastern University (China) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen